Pudafensine clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2022
How each study uses pudafensine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2022 (1)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Initiator Pharma (3)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test pudafensine.
- Dec 2026A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia)Phase 2 · Initiator Pharma
Studies
Open first, then newest update. How each study uses pudafensine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia)Active, not recruitingPhase 2Initiator PharmaNCT07391241Written as Pudafensine
- Bioavailability Study to Compare Liquid vs Two Solid Formulations of IP2015Status unknownPhase 1Initiator PharmaNCT05728671Written as IP2015
- Study to Investigate the Pharmacodynamic Effects of IP2015 in Healthy Male Subjects Using the Intradermal Capsaicin ModelStatus unknownPhase 1Initiator PharmaNCT05181852Written as IP2015, dose 1
Codes
What other systems call pudafensine · ClinicalTrials.gg INT017159
- UNII (FDA) L9NG7US8GEPUDAFENSINEOne source FDA
- NCI Thesaurus C206975PudafensineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | L9NG7US8GE | PUDAFENSINE | One source FDA |
| NCI Thesaurus | C206975 | Pudafensine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.